Showing results (541-550 of 574) with videos related to
Sort By:
Pageof 58
Proceedings of the National Academy of Sciences of the United States of America|August 30, 1994
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal agingJ Näslund, A Schierhorn, U Hellman, et al.Neuroscience Letters|January 22, 2000
Tau gene polymorphisms and apolipoprotein E epsilon4 may interact to increase risk for Alzheimer's diseaseL Lilius, S Froelich Fabre, H Basun, et al.Proceedings of the National Academy of Sciences of the United States of America|December 6, 1994
Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutationM Citron, C Vigo-Pelfrey, D B Teplow, et al.FEBS Letters|November 14, 1994
Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutationJ A Johnston, R F Cowburn, S Norgren, et al.Neurobiology of Aging|January 1, 1983
Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT)C G Gottfries, R Adolfsson, S M Aquilonius, et al.Lancet (London, England)|August 23, 1986
Defective brain microtubule assembly in Alzheimer's diseaseK Iqbal, I Grundke-Iqbal, T Zaidi, et al.Brain Research|May 25, 1996
Apolipoprotein E (apoE) levels in brains from Alzheimer disease patients and controlsT Pirttilä, H Soininen, O Heinonen, et al.Neuroscience Letters|March 14, 2000
Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in womenK M Mattila, K Axelman, J O Rinne, et al.Journal of Internal Medicine|March 28, 2018
Targeting Alzheimer's disease with gene and cell therapiesR Loera-Valencia, A Piras, M A M Ismail, et al.Journal of Internal Medicine|May 12, 2016
Current and future treatment of amyloid diseasesM Ankarcrona, B Winblad, C Monteiro, et al.Pageof 58